Targeted Lipidomics of Oxylipins (Oxygenated Fatty Acids)

Significance of the Topic

The study of oxylipins, oxygenated derivatives of polyunsaturated fatty acids, is critical because these bioactive lipids regulate key physiological processes such as inflammation, vascular tone, and coagulation. Alterations in oxylipin profiles have been linked to cardiovascular disease, immune response, and tissue injury. A rapid, sensitive, and comprehensive analytical workflow is essential to unravel their roles in health and disease and to identify potential biomarkers for diagnosis and prognosis.

Objectives and Study Overview

This work aimed to develop and validate a high-throughput method for targeted lipidomics of oxylipins in human plasma. The workflow combines mixed-mode solid-phase extraction with ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-ESI-MRM) to detect and semi-quantify over 100 oxylipins, including prostaglandins, thromboxanes, leukotrienes, isoprostanes, diols, hydroxy acids, and epoxides. The method was designed for routine analysis, ensuring efficient separation of isomers and high analytical specificity.

Methodology and Instrumentation

Sample Preparation

• Plasma aliquots (50–250 µL) were spiked with antioxidants and a mixture of 16 stable isotope-labeled internal standards.
• Samples were diluted and applied to Oasis MAX mixed-mode SPE cartridges to remove phospholipids and other interferences.
• Analytes were eluted, dried under nitrogen, reconstituted in a 50/50 methanol/acetonitrile solution, and injected into the UPLC-MS/MS system.

Chromatographic Conditions

• Column: ACQUITY UPLC BEH C18, 2.1×100 mm, 1.7 µm.
• Mobile phases: water with 0.1% acetic acid (A) and acetonitrile/isopropanol 90/10 (B).
• Flow rate: 0.6 mL/min, column temperature 40 °C, 10-minute gradient elution.

Mass Spectrometry

• Xevo TQ-S operated in negative electrospray ionization (ESI) mode.
• Multiple reaction monitoring (MRM) transitions were optimized for 107 oxylipins, with compound-specific cone voltages and collision energies.
• Retention time scheduling minimized overlap and maximized dwell time for each MRM transition.

Used Instrumentation

• ACQUITY UPLC System with BEH C18 column.
• Xevo TQ-S triple quadrupole mass spectrometer.
• Oasis MAX mixed-mode SPE cartridges.
• TargetLynx Application Manager for data processing.

Main Results and Discussion

The optimized UPLC gradient achieved separation of isobaric and isomeric oxylipins (e.g., PGE2 vs. PGD2) within 10 minutes. Calibration curves for most analytes showed excellent linearity (R2 > 0.99). The method reproducibly quantified 107 endogenous oxylipins in plasma, covering enzymatic (COX, LOX, CYP450) and non-enzymatic pathways. The use of stable isotope-labeled standards enabled compensation for extraction variability and matrix effects. This high-throughput platform supports large-scale studies and comparative profiling of inflammatory and metabolic states.

Benefits and Practical Applications

• High sensitivity and specificity for low-abundance oxylipins.
• Rapid analysis time compatible with large sample cohorts.
• Wide coverage of lipid mediator classes, including prostanoids, leukotrienes, isoprostanes, epoxides, and diols.
• Potential for biomarker discovery in clinical and nutritional research.
• Adaptable to other biological matrices (urine, tissue extracts) with minor protocol modifications.

Future Trends and Opportunities

Advances in high-resolution mass spectrometry and automated sample preparation will further enhance oxylipin profiling. Integration with global metabolomics and lipidomics platforms may uncover novel signaling pathways. Emerging microfluidic SPE devices and faster chromatography columns will reduce sample volume and analysis time. Machine learning approaches applied to large oxylipin datasets could identify biomarkers for precision medicine and guide therapeutic interventions.

Conclusion

This validated SPE-UPLC-ESI-MRM assay provides a robust, high-throughput solution for targeted profiling of over 100 oxylipins in plasma. Its combination of efficient sample cleanup, rapid UPLC separation, and sensitive MRM detection supports diverse applications in biomedical research, clinical studies, and drug development.

References

1. Lundstrom SL, Saluja R, Adner M, Haeggstrom JZ, Nilsson GP, Wheelock CE. Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. J Lipid Res. 2012 Oct;3. Epub ahead of print.
2. Strassburg K, Huijbrechts AM, Kortekaas KA, et al. Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem. 2012 Sep;404(5):1413–26.
3. Sterz K, Scherer G, Ecker J. A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids. J Lipid Res. 2012 May;53(5):1026–36.
4. Nicolaou A, Masoodi M, Mir A. Lipidomic analysis of prostanoids by liquid chromatography-electrospray tandem mass spectrometry. Methods Mol Biol. 2009;579:271–86.
5. Astarita G, Kendall AC, Dennis EA, Nicolaou A. Targeted lipidomics strategies for oxygenated metabolites of polyunsaturated fatty acids. Biochim Biophys Acta. 2014 Dec 5:S1388-1981(14)00251–0.